ParaZero (PRZO) Technologies announced the successful completion of a joint field trial of its DropAir system for the precision delivery of blood units. The trial was conducted in collaboration with MAFAT, the Israeli Ministry of Health, and the Israel Defense Forces, including the Medical Corps and Technology & Logistics Directorate. During the trial, blood Transfusions were dropped from an altitude of 200 meters AGL using ParaZero’s DropAir system. Following recovery, the Transfusions were inspected by doctors at the Rambam Medical center and confirmed to be undamaged and fully suitable for transfusion to humans.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PRZO:
- ParaZero Successfully Trials Counter-Drone System in Israel
- ParaZero Technologies Reports First Half 2025 Financial Results
- ParaZero Achieves 100% Success in Latest Drone Defense Test
- ParaZero concludes field test of Defend Air Hand-Held Net Gun System
- ParaZero Secures Defense Order for Counter-Drone Technology